格列齐特（Ｇｌｉｃｌａｚｉｄｅ）片系第三代口服磺酰脲类降血糖药，其作用机理是选择性作用于胰岛β细胞，促进分泌胰岛素，能持久控制血糖水平，具有抗血小板功能，改善糖尿病患者异常的凝血功能，疗效良好，副作用少。在治疗非胰岛素依赖性糖尿病和血管病变性糖尿病上... Gliclazide is the third-generation oral sulfonylurea hypoglycemic agent. Its mechanism of action is that it selectively acts on islet β-cells, promotes the secretion of insulin, long-term control of blood glucose level, has anti-platelet function, improves diabetes Patients with abnormal coagulation, good effect, fewer side effects. In the treatment of non-insulin-dependent diabetes and vascular disease diabetes ...